A doctor involved in testing a COVID-19 vaccine developed by the biotech company Moderna said he was “cautiously optimistic” that it would be available by the end of the year; an early-stage trial of a Chinese vaccine showed “promising” results; Thailand’s government said that it hoped to distribute an inexpensive vaccine throughout Southeast Asia next year, in an attempt to avert a global shortage; the U.S. national security adviser vowed that the United States would be the first country to develop an effective vaccine and other treatments for the coronavirus and would then “share them with the world”; and a researcher at Oxford University—whose vaccine study may be discontinued because of decreasing infection rates in the United Kingdom—said, of other countries developing a vaccine on the basis of their work, “We might feel a little peculiar about that. We got there first, but everyone else piles in. We might feel that we've done the heavy lifting. But actually we wouldn't care.”
Weekly Review
Weekly Review
Weekly Review
A doctor involved in testing a COVID-19 vaccine developed by the biotech company Moderna said he was “cautiously optimistic” that it would be available by the end of the year; an early-stage trial of a Chinese vaccine showed “promising” results; Thailand’s government said that it hoped to distribute an inexpensive vaccine throughout Southeast Asia next year, in an attempt to avert a global shortage; the U.S. national security adviser vowed that the United States would be the first country to develop an effective vaccine and other treatments for the coronavirus and would then “share them with the world”; and a researcher at Oxford University—whose vaccine study may be discontinued because of decreasing infection rates in the United Kingdom—said, of other countries developing a vaccine on the basis of their work, “We might feel a little peculiar about that. We got there first, but everyone else piles in. We might feel that we've done the heavy lifting. But actually we wouldn't care.”